Product Information
TOBRAMYCIN 80 MG/2 ML VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $0.6528 per ML under NDC 63323030602. Its NADAC has been published 301 times since Nov 28, 2013.
Strength
40 mg/mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323030602
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Last Updated
6/17/2026
Active Ingredients
TOBRAMYCIN SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA065122On Market Since
11/23/2005
Pharmacological Classes
Price Statistics
The NADAC for TOBRAMYCIN 80 MG/2 ML VIAL has been published 301 times since Nov 28, 2013, and over the history we have for it it has declined 48.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6528 per ML |
|---|---|
| All-time high | $1.4932 (Jan 15, 2014) |
| All-time low | $0.5997 (Mar 18, 2026) |
| 52-week high | $0.8372 |
| 52-week low | $0.5997 |
| Median price | $0.8495 |
| Average price | $0.8512 |
| Largest weekly change | +101.1% (Aug 20, 2014) |
| Weeks tracked | 301 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the TOBRAMYCIN SULFATE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of TOBRAMYCIN 80 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for TOBRAMYCIN 80 MG/2 ML VIAL, manufactured by Fresenius Kabi USA, LLC, is $0.6528 per ML (NDC 63323030602), effective Jun 24, 2026.
How has the price of TOBRAMYCIN 80 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for TOBRAMYCIN 80 MG/2 ML VIAL has declined 48.8%. It has been tracked across 301 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TOBRAMYCIN 80 MG/2 ML VIAL?
Since Nov 28, 2013, the NADAC for TOBRAMYCIN 80 MG/2 ML VIAL has ranged from a low of $0.5997 (Mar 18, 2026) to a high of $1.4932 (Jan 15, 2014), with a median of $0.8495 per ML.
Are there cheaper alternatives to TOBRAMYCIN 80 MG/2 ML VIAL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of TOBRAMYCIN 80 MG/2 ML VIAL, so no direct lower-cost alternative is listed.
Who manufactures TOBRAMYCIN 80 MG/2 ML VIAL?
TOBRAMYCIN 80 MG/2 ML VIAL (NDC 63323030602) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification